50 A29789 ( pir) ( 17, 0) mucin - sheep (fragment) SSVPGESATPQQPGALSESTTQLPGVTGTSAVTGSEPGLPSTGVSGLPGT SS....S.T.......S.STT.....T.TS..T.S.....ST..S....T 312 NBHUA2 ( pir) ( 1, 0) leucine-rich alpha-2-glycoprotein - human VTLSPKDCQVFRSDHGSSISCQPPAEIPGYLPADTVHLAVEFFNLTHLPANLLQGASKLQELHLSSNGLESLSPEFLRPV PQLRVLDLTRNALTGLPPGLFQASATLDTLVLKENQLEVLEVSWLHGLKALGHLDLSGNRLRKLPPGLLANFTLLRTLDL GENQLETLPPDLLRGPLQLERLHLEGNKLQVLGKDLLLPQPDLRYLFLNGNKLARVAAGAFQGLRQLDMLDLSNNSLASV PEGLWASLGQPNWDMRDGFDISGNPWICDQNLSDLYRWLQAQKDKMFSQNDTRCAGPEAVKGQTLLAVAKSQ .T.........................................N.................................... ......................................................................N......... .........................................................................N...... ..............................N..................N...................... 626 KGHUH1 ( pir) ( 9, 0) kininogen, HMW I precursor QESQSEEIDCNDKDLFKAVDAALKKYNSQNQSNNQFVLYRITEATKTVGSDTFYSFKYEIKEGDCPVQSGKTWQDCEYKD AAKAATGECTATVGKRSSTKFSVATQTCQITPAEGPVVTAQYDCLGCVHPISTQSPDLEPILRHGIQYFNNNTQHSSLFM LNEVKRAQRQVVAGLNFRITYSIVQTNCSKENFLFLTPDCKSLWNGDTGECTDNAYIDIQLRIASFSQNCDIYPGKDFVQ PPTKICVGCPRDIPTNSPELEETLTHTITKLNAENNATFYFKIDNVKKARVQVVAGKKYFIDFVARETTCSKESNEELTE SCETKKLGQSLDCNAEVYVVPWEKKIYPTVNCQPLGMISLMKRPPGFSPFRSSRIGEIKEETTVSPPHTSMAPAQDEERD SGKEQGHTRRHDWGHEKQRKHNLGHGHKHERDQGHGHQRGHGLGHGHEQQHGLGHGHKFKLDDDLEHQGGHVLDHGHKHK HGHGHGKHKNKGKKNGKHNGWKTEHLASSSEDSTTPSAQTQEKTEGPTPIPSLAKPGVTVTFSDFQDSDLIATMMPPISP APIQSDDDWIPDIQTDPNGLSFNPISDFPDTTSPKCPGRPWKSVSEINPTTQMKESYYFDLTDGLS .............................n.................................................. ......................................................................n......... ..........................n..................................................... ...................................n............................................ ..............................................................T................. ................................................................................ ..................................T........T...T..........T.............T.....S. ..............T..................................T................ 79 LPHUC3 ( pir) ( 1, 0) apolipoprotein C-III precursor SEAEDASLLSFMQGYMKHATKTAKDALSSVQESQVAQQARGWVTDGFSSLKDYWSTVKDKFSEFWDLDPEVRPTSAVAA .........................................................................T..... 383 DHHU ( pir) ( 7, 0) Ig delta chain C region APTKAPDVFPIISGCRHPKDNSPVVLACLITGYHPTSVTVTWYMGTQSQPQRTFPEIQRRDSYYMTSSQLSTPLQQWRQG EYKCVVQHTASKSKKEIFRWPESPKAQASSVPTAQPQAEGSLAKATTAPATTRNTGRGGEEKKKEKEKEEQEERETKTPE CPSHTQPLGVYLLTPAVQDLWLRDKATFTCFVVGSDLKDAHLTWEVAGKVPTGGVEEGLLERHSNGSQSQHSRLTLPRSL WNAGTSVTCTLNHPSLPPQRLMALREPAAQAPVKLSLNLLASSDPPEAASWLLCEVSGFSPPNILLMWLEDQREVNTSGF APARPPPQPGSTTFWAWSVLRVPAPPSPQPATYTCVVSHEDSRTLLNASRSLEVSYVTDHGPM ................................................................................ ............................SS..T............TT...TT............................ ................................................................N............... ...........................................................................N.... ..............................................N................ 353 ALC1_HUMAN (sprot) ( 5, 0) IG ALPHA-1 CHAIN C REGION. ASPTSPKVFPLSLCSTQPDGNVVIACLVQGFFPQEPLSVTWSESGQGVTARNFPPSQDASGDLYTTSSQLTLPATQCLAG KSVTCHVKHYTNPSQDVTVPCPVPSTPPTPSPSTPPTPSPSCCHPRLSLHRPALEDLLLGSEANLTCTLTGLRDASGVTF TWTPSSGKSAVQGPPERDLCGCYSVSSVLPGCAEPWNHGKTFTCTAAYPESKTPLTATLSKSGNTFRPEVHLLPPPSEEL ALNELVTLTCLARGFSPKDVLVRWLQGSQELPREKYLTWASRQEPSQGTTTFAVTSILRVAAEDWKKGDTFSCMVGHEAL PLAFTQKTIDRLAGKPTHVNVSVVMAEVDGTCY ................................................................................ ........................S.....S.S.....S.S......................N................ ................................................................................ ................................................................................ ...................N............. 145 KTHUB ( pir) ( 4, 0) choriogonadotropin beta chain precursor SKEPLRPRCRPINATLAVEKEGCPVCITVNTTICAGYCPTMTRVLQGVLPALPQVVCNYRDVRFESIRLPGCPRGVNPVV SYAVALSCQCALCRRSTTDCGGPKDHPLTCDDPRFQDSSSSKAPPPSLPSPSRLPGPSDTPILPQ ............N................N.................................................. ........................................S.....S....S.....S....... 240 CTHUP ( pir) ( 1, 0) corticotropin / lipotropin - human WCLESSQCQDLTTESNLLECIRACKPDLSAETPMFPGNGDEQPLTENPRKYVMGHFRWDRFGRRNSSSSGSSGAGQKRED VSAGEDCGPLPEGGPEPRSDGAKPGPREGKRSYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEFKRELTGQRLR EGDGPDGPAATAQGPGDLEHSLLVAAEKKDEGPYRMEHFRWGSPPKDKRYGGFMTSEKSQTPLVTLFKNAIIKNAYKKGE ............................................T...................N............... ................................................................................ ................................................................................ 786 PLBO ( pir) ( 1, 0) plasmin (EC 3.4.21.7) - bovine plasminogen. DLLDDYVNTQGASLLSLSRKNLAGRSVEDCAAKCEEETDFVCRAFQYHSKEQQCVVMAENSKNTPVFRMRDVILYEKRIY LLECKTGNGQTYRGTTAETKSGVTCQKWSATSPHVPKFSPEKFPLAGLEENYCRNPDNDENGPWCYTTDPDKRYDYCDIP ECEDKCMHCSGENYEGKIAKTMSGRDCQAWDSQSPHAHGYIPSKFPNKNLKMNYCRNPDGEPRPWCFTTDPQKRWEFCDI PRCTTPPPSSGPKYQCLKGTGKNYGGTVAVTESGHTCQRWSEQTPHKHNRTPENFPCKNLEENYCRNPDGEKAPWCYTTN SEVRWEYCTIPSCESSPLSTERMDVPVPPEQTPVPQDCYHGNGQSYRGTSSTTITGRKCQSWSSMTPHRHLKTPENYPNA GLTMNYCRNPDADKSPWCYTTDPRVRWEFCNLKKCSETPEQVPAAPQAPGVENPPEADCMIGTGKSYRGKKATTVAGVPC QEWAAQEPHHHSIFTPETNPQSGLERNYCRNPDGDVNGPWCYTMNPRKLFDYCDVPQCESSFDCGKPKVEPKKCSGRIVG GCVSKPHSWPWQVSLRRSSRHFCGGTLISPKWVLTAAHCLDNILALSFYKVILGAHNEKVREQSVQEIPVSRLFREPSQA DIALLKLSRPAIITKEVIPACLPPPNYMVAARTECYITGWGETQGTFGEGLLKEAHLPVIENKVCNRNEYLDGRVKPTEL CAGHLIGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSPYVPWIEETMRRN ................................................................................ ................................................................................ ................................................................................ ................................................N............................... ..................S............................................................. ................................................................................ ................................................................................ ................................................................................ ................................................................................ .................................................................. 790 PLHU ( pir) ( 1, 0) plasmin precursor - human plasminogen EPLDDYVNTQGASLFSVTKKQLGAGSIEECAAKCEEDEEFTCRAFQYHSKEQECVIMAENRKSSIIRMRDVVLFEKKVYL SECKTGDGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILE CEEECMHCSGENYDGKISKTMSGLECQAWDSQSPHAHGYIPSKFPNKNLKKNYCRNPDRELRPWCFTTDPNKRWELCDIP RCTTPPPSSGPTYQCLKGTGENYRGNVAVTVSGHTCQHWSAQTPHTHNRTPENFPCKNLDENYCRNPDGKRAPWCHTTNS QVRWEYCKIPSCDSSPVSTEELAPTAPPELTPVVQDCYHGDGQSYRGTSSTTTTGKKCQSWSSMTPHRHQKTPENYPNAG LTMNYCRNPDADKGPWCFTTDPSVRWEYCNLKKCSGTEASVVAPPPVVLLPNVETPSEEDCMFGNGKGYRGKRATTVTGT PCQDWAAQEPHRHSIFTPETNPRAGLEKNYCRNPDGDVGGPWCYTTNPRKLYDYCDVPQCAAPSFDCGKPQVEPKKCPGR VVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLE PTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQ STELCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVMRNN ................................................................................ ................................................................................ ................................................................................ ...............................................N................................ ........................T....................................................... ................................................................................ ................................................................................ ................................................................................ ................................................................................ ...................................................................... 246 KQHU ( pir) ( 3, 0) tissue kallikrein, pancreatic kallikrein AAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESF PHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTQEPEVGSTCLASGWGSIEPENFSFPDDLQCVD LKILPNDECEKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIED TIAENS ............................................................................S... .....N.S...N........................................................N.S......... ................................................................................ ...... 603 KNH1_BOVIN (sprot) ( 12, 0) KININOGEN, HMW I PRECURSOR QESSQEIDCNDQDVFKAVDAALTKYNSENKSGNQFVLYRITEVARMDNPDTFYSLKYQIKEGDCPFQSNKTWQDCDYKDS AQAATGECTATVAKRGNMKFSVAIQTCLITPAEGPVVTAQYECLGCVHPISTKSPDLEPVLRYAIQYFNNNTSHSHLFDL KEVKRAQRQVVSGWNYEVNYSIAQTNCSKEEFSFLTPDCKSLSSGDTGECTDKAHVDVKLRISSFSQKCDLYPVKDFVQP PTRLCAGCPKPIPVDSPDLEEPLSHSIAKLNAEHDGAFYFKIDTVKKATVQVVAGLKYSIVFIARETTCSKGSNEELTKS CEINIHGQILHCDANVYVVPWEEKVYPTVNCQPLGQTSLMKRPPGFSPFRSVQVMKTEGSTTVSLPHSAMSPVQDEERDS GKEQGPTHGHGWDHGKQIKLHGLGLGHKHKHDQGHGHHGSHGLGHGHQKQHGLGHGHKHGHGHGKHKNKGKNNGKHYDWR TPYLASSYEDSTTSSAQTQEKTEETTLSSLAQPGVAITFPDFQDSDLIATVMPNTLPPHTESDDDWIPDIQTEPNSLAFK LISDFPETTSPKCPSRPWKPVNGVNPTVEMKESHDFDLVDALL ....................................................................N........... .....................................T...............................N.......... ..................N......N...................................................... ................................................................................ ...........................................................STT.....S............ ................................................................................ .............S.......T...T...........T...........T....T................T........ ........................................... 52 A05273 ( pir) ( 7, 0) glycophorin - dog (fragment) QDVTEIIPHQISSPLPTQAGFISTEDPSFNTPSTREDPSGTMYQHLPDGGQK ...........SS...T.....ST......T.......S............. 65 A16604 ( pir) ( 10, 0) kappa-casein - human (fragment) IAIPPKKIQDKIIIPTINTIATVEPTPAPATEPTVDSVVTPEATTESIITSTPETPTVAVPTTSA ...............T.........T....T..T.....T....T....T.T.........TT.. 33 LEUK_RAT(p1) (sprot) ( 13, 0) LEUKOSIALIN (fragment) ENLPNTMTMLPFTPNSESPSTSEALSTYSSIAT .....T.T....T..S.S.STS...ST.SS..T 19 LEUK_RAT(p2) (sprot) ( 6, 0) LEUKOSIALIN (fragment) SSGVASDPPVTITNPATSS S....S......T...TSS 19 LEUK_RAT(p3) (sprot) ( 5, 0) LEUKOSIALIN (fragment) ATGSLGPSKETHGLSATIA .T.S...S......S.T.. 72 LEUK_HUMAN(p1) (sprot) ( 16, 0) LEUKOSIALIN (fragment) STTAVQTPTSGEPLVSTSEPLSSKMYTTSITSDPKADSTGDQTSALPPSTSINEGSPLWTSIGASTGSPLPE .TT...T.TS.....STS...SS...TTS.T.......T..........T...................... 31 LEUK_HUMAN(p2) (sprot) ( 5, 0) LEUKOSIALIN (fragment) TTYQEVSIKMSSVPQETPHATSHPAVPITAN ......S...S.....T...TS......... 14 LEUK_HUMAN(p3) (sprot) ( 2, 0) LEUKOSIALIN (fragment) VTGGTITTNSPETS ......TT...... 17 LEUK_HUMAN(p4) (sprot) ( 2, 0) LEUKOSIALIN (fragment) ATVSLETSKGTSGPPVT .T....T.......... 166 EPO_HUMAN (sprot) ( 1, 0) ERYTHROPOIETIN . - HOMO SAPIENS (HUMAN). APPRLICDSRVLERYLLEAKEAENITTGCAEHCSLNENITVPDTKVNFYAWKRMEVGQQAVEVWQGLALLSEAVLRGQAL LVNSSQPWEPLQLHVDKAVSGLRSLTTLLRALGAQKEAISPPDAASAAPLRTITADTFRKLFRVYSNFLRGKLKLYTGEA CRTGDR .......................N.............N.......................................... ..N..........................................S.................................. ...... 209 CASB_BOVIN (sprot) ( 3, 1) BETA CASEIN . - BOS TAURUS (BOVINE). RELEELNVPGEIVESLSSSEESITRINKKIEKFQSEEQQQTEDELQDKIHPFAQTQSLVYPFPGPIPNSLPQNIPPLTQT PVVVPPFLQPEVMGVSKVKEAMAPKHKEMPFPKYPVEPFTESQSLTLTDVENLHLPLPLLQSWMHQPHQPLPPTVMFPPQ SVLSLSQSKVLPVPQKAVPYPQRDMPIQAFLLYQEPVLGPVRGPFPIIV ........................................................S......................T ................................................................................ .......S......................................... 320 ALC_MOUSE (sprot) ( 1, 0) IG ALPHA CHAIN C REGION. (MOUSE). ESARNPTIYPLTLPPALSSDPVIIGCLIHDYFPSGTMNVTWGKSGKDITTVNFPPALASGGRYTMSNQLTLPAVECPEGE SVKCSVQHDSNPVQELDVNCSGPTPPPPITIPSCQPSLSLQRPALEDLLLGSDASITCTLNGLRNPEGAVFTWEPSTGKD AVQKKAVQNSCGCYSVSSVLPGCAERWNSGASFKCTVTHPESGTLTGTIAKVTVNTFPPQVHLLPPPSEELALNELLSLT CLVRAFNPKEVLVRWLHGNEELSPESYLVFEPLKEPGEGATTYLVTSVLRVSAETWKQGDQYSCMVGHEALPMNFTQKTI .....................................N.......................................... ....................S........................................................... ................................................................................ ................................................................................ 133 ICHU2 ( pir) ( 1, 0) interleukin-2 precursor - human APTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHL RPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRWITFCQSIISTLT ..T............................................................................. ..................................................... 790 PLMN_PIG (sprot) ( 1, 0) PLASMINOGEN . - SUS SCROFA (PIG). DSLDDYVNTQGAFLFSLSRKQVAARSVEECAAKCEAETNFICRAFQYHSKDQQCVVMAENSKTSPIARMRDVVLFEKRIY LSECKTGNGKNYRGTTSKTKSGVICQKWSVSSPHIPKYSPEKFPLAGLEENYCRNPDNDEKGPWCYTTDPETRFDYCDIP ECEDECMHCSGEHYEGKISKTMSGIECQSWGSQSPHAHGYLPSKFPNKNLKMNYCRNPDGEPRPWCFTTDPNKRWEFCDI PRCTTPPPTSGPTYQCLKGRGENYRGTVSVTASGHTCQRWSAQSPHKHNRTPENFPCKNLEENYCRNPDGETAPWCYTTD SEVRWDYCKIPSCGSSTTSTEHLDAPVPPEQTPVAQDCYRGNGESYRGTSSTTITGRKCQSWVSMTPHRHEKTPGNFPNA GLTMNYCRNPDADKSPWCYTTDPRVRWEYCNLKKCSETEQQVTNFPAIAQVPSVEDLSEDCMFGNGKRYRGKRATTVAGV PCQEWAAQEPHRHSIFTPETNPRAGLEKNYCRNPDGDDNGPWCYTTNPQKLFDYCDVPQCVTSSFDCGKPKVEPKKCPAR VVGGCVSIPHSWPWQISLRYRYRGHFCGGTLISPEWVLTAKHCLEKSSSPSSYKVILGAHEEYHLGEGVQEIDVSKLFKE PSEADIALLKLSSPAVITDKVIPACLPTPNYVVADRTACYITGWGETKGTYGAGLLKEARLPVIENKVCNRYEYLGGKVS PNELCAGHLAGGIDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCALPNKPGVYVRVSRFVTWIEEIMRRN ................................................................................ ................................................................................ ................................................................................ ........T....................................................................... ................................................................................ ................................................................................ ................................................................................ ................................................................................ ................................................................................ ...................................................................... 49 GFHOE.1 ( pir) ( 10, 0) (e) glycophorin HA - horse QTIATGSPPIAGTSDLSTITSAATPTFTTEQDGREQGDGLQLAHDFSQP .T..T.S.....T...ST.TS..T...T..................... 62 GFPGE.1 ( pir) ( 10, 0) (e) glycophorin - pig TETPVTGEQGSATPGNVSNATVTAGKPSATSPGVMTIKNTTAVVQKETGVPESYHQDFSHAE T....T....S.T.....N.T.T......TS.......N.T......T.............. 439 HEMO_HUMAN (sprot) ( 1, 0) HEMOPEXIN (BETA-1B-GLYCOPROTEIN) TPLPPTSAHGNVAEGETKPDPDVTERCSDGWSFDATTLDDNGTMLFFKGEFVWKSHKWDRELISERWKNFPSPVDAAFRQ GHNSVFLIKGDKVWVYPPEKKEKGYPKLLQDEFPGIPSPLDAAVECHRGECQAEGVLFFQGDREWFWDLATGTMKERSWP AVGNCSSALRWLGRYYCFQGNQFLRFDPVRGEVPPRYPRDVRDYFMPCPGRGHGHRNGTGHGNSTHHGPEYMRCSPHLVL SALTSDNHGATYAFSGTHYWRLDTSRDGWHSWPIAHQWPQGPSAVDAAFSWEEKLYLVQGTQVYVFLTKGGYTLVSGYPK RLEKEVGTPHGIILDSVDAAFICPGSSRLHIMAGRRLWWLDLKSGAQATWTELPWPHEKVDGALCMEKSLGPNSCSANGP GLYLIHGPNLYCYSDVEKLNAAKALPQPQNVTSLLGCTH T.......................................N....................................... ................................................................................ ...N....................................................N.....N................. ................................................................................ ................................................................................ .............................N......... 373 BOHUS ( pir) ( 1, 0) sex hormone-binding globulin precursor LRPVLPTQSAHDPPAVHLSNGPGQEPIAVMTFDLTKITKTSSSFEVRTWDPEGVIFYGDTNPKDDWFMLGLRDGRPEIQL HNHWAQLTVGAGPRLDDGRWHQVEVKMEGDSVLLEVDGEEVLRLRQVSGPLTSKRHPIMRIALGGLLFPASNLRLPLVPA LDGCLRRDSWLDKQAEISASAPTSLRSCDVESNPGIFLPPGTQAEFNLRDIPQPHAEPWAFSLDLGLKQAAGSGHLLALG TPENPSWLSLHLQDQKVVLSSGSGPGLDLPLVLGLPLQLKLSMSRVVLSQGSKMKALALPPLGLAPLLNLWAKPQGRLFL GALPGEDSSTSFCLNGLWAQGQRLDVDQALNRSHEIWTHSCPQSPGNGTDASH ......T......................................................................... ................................................................................ ................................................................................ ................................................................................ ..............................N...............N...... 333 HCHU ( pir) ( 2, 0) alpha-1-microglobulin GPVPTPPDNIQVQENFNISRIYGKWYNLAIGSTCPWLKKIMDRMTVSTLVLGEGATEAEISMTSTRWRKGVCEETSGAYE KTDTDGKFLYHKSKWNITMESYVVHTNYDEYAIFLTKKFSRHHGPTITAKLYGRAPQLRETLLQDFRVVAQGVGIPEDSI FTMADRGECVPGEQEPEPILIPRVRRAVLPQEEEGSGGGQLVTEVTKKEDSCQLGYSAGPCMGMTSRYFYNGTSMACETF QYGGCMGNGNNFVTEKECLQTCRTVAACNLPIVRGPCRAFIQLWAFDAVKGKCVLFPYGGCQGNGNKFYSEKECREYCGV PGDGDEELLRFSN ....T...........N............................................................... ...............N................................................................ ...................................S..................................n......... ................................................................................ ............. 169 MBBOB ( pir) ( 1, 0) myelin basic protein - bovine AAQKRPSQRSKYLASASTMDHARHGFLPRHRDTGILDSLGRFFGSDRGAPKRGSGKDGHHAARTTHYGSLPQKAQGHRPQ DENPVVHFFKNIVTPRTPPPSQGKGRGLSLSRFSWGAEGQKPGFGYGGRASDYKSAHKGLKGHDAQGTLSKIFKLGGRDS RSGSPMARR ................................................................................ .............T..T............................................................... ......... 127 FQHUGM ( pir) ( 4, 0) granulocyte-macrophage colony-stimulating factor APARSPSPSTQPWEHVNAIQEARRLLNLSRDTAAEMNETVEVISEMFDLQEPTCLQTRLELYKQGLRGSLTKLKGPLTMM ASHYKQHCPPTPETSCATQIITFESFKENLKDFLLVIPFDCWEPVQE ....S.S.ST................n.........n........................................... ............................................... 128 GFHUC ( pir) ( 12, 0) glycophorin C - human component D; PAS-2' MWSTRSPNSTAWPLSLEPDPGMASASTTMHTTTIAEPDPGMSGWPDGRMETSTPTIMDIVVIAGVIAAVAIVLVSLLFVM LRYMYRHKGTYHTNEAKGTEFAESADAALQGDPALQDAGDSSRKEYFI ..ST.S.NST....S........S.STT..TTT........S...................................... ................................................ 60 GFHUE ( pir) ( 16, 0) glycophorin A(M) - human MN-glycoprotein; PAS-2 SSTTGVAMHTSTSSSVTKSYISSQTNDTHKRDTYAATPRAHEVSEISVRTVYPPEEETGE .STT.....TSTS...T.S..S..TN......T...T......S..S..T.......... 389 LMP1_HUMAN (sprot) ( 6, 0) LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEIN 1 AMFMVKNGNGTACIMANFSAAFSVNYDTKSGPKNMTFDLPSDATVVLNRSSCGKENTSDPSLVIAFGRGHTLTLNFTRNA TRYSVQLMSFVYNLSDTHLFPNASSKEIKTVESITDIRADIDKKYRCVSGTQVHMNNVTVTLHDATIQAYLSNSSFSRGE TRCEQDRPSPTTAPPAPPSPSPSPVPKSPSVDKYNVSGTNGTCLLASMGLQLNLTYERKDNTTVTRLLNINPNKTSASGS CGAHLVTLELHSEGTTVLLFQFGMNASSSRFFLQGIQLNTILPDARDPAFKAANGSLRALQATVGNSYKCNAEEHVRVTK AFSVNIFKVWVQAFKVEGGQFGSVEECLLDENSTLIPIAVGGALAGLVLIVLIAYLVGRKRSHAGYQTI ........N.......N................N.............N.......N..................N...N. ............N........N..................................N...............N....... ........S.TT......S.S.S...........N....N............N.......N...........N....... ........................N............................N.......................... ...............................n..................................... 380 LMP2_HUMAN (sprot) ( 10, 0) LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEIN 2 LELNLTDSENATCLYAKWQMNFTVRYETTNKTYKTVTISDHGTVTYNGSICGDDQNGPKIAVQFGPGFSWIANFTKAAST YSIDSVSFSYNTGDNTTFPDAEDKGILTVDELLAIRIPLNDLFRCNSLSTLEKNDVVQHYWDVLVQAFVQNGTVSTNEFL CDKDKTSTVAPTIHTTVPSPTTTPTPKEKPEAGTYSVNNGNDTCLLATMGLQLNITQDKVASVININPNTTHSTGSCRSH TALLRLNSSTIKYLDFVFAVKNENRFYLKEVNISMYLVNGSVFSIANNNLSYWMPPSSYMCNKEQTVSVSGAFQINTFDL RVQPFNVTQGKYSTAQDCSADDDNFLVPIAVGAALAGVLILVLLAYFIGLKHHHAGYEQF ...N.....N..........N........N................N.........................N....... ..............N.......................................................N......... ......ST...T..TT..S.TTT.T...............N............N..............N........... ......N........................N......N.........N............................... .....N...................................................... 992 ITAB_HUMAN(HPA-3B) (sprot) ( 2, 0) PLATELET MEMBRANE GLYCOPROTEIN IIB LNLDPVQLTFYAGPNGSQFGFSLDFHKDSHGRVAIVVGAPRTLGPSQEETGGVFLCPWRAEGGQCPSLLFDLRDETRNVG SQTLQTFKARQGLGASVVSWSDVIVACAPWQHWNVLEKTEEAEKTPVGSCFLAQPESGRRAEYSPCRGNTLSRIYVENDF SWDKRYCEAGFSSVVTQAGELVLGAPGGYYFLGLLAQAPVADIFSSYRPGILLWHVSSQSLSFDSSNPEYFDGYWGYSVA VGEFDGDLNTTEYVVGAPTWSWTLGAVEILDSYYQRLHRLRAEQMASYFGHSVAVTDVNGDGRHDLLVGAPLYMESRADR KLAEVGRVYLFLQPRGPHALGAPSLLLTGTQLYGRFGSAIAPLGDLDRDGYNDIAVAAPYGGPSGRGQVLVFLGQSEGLR SRPSQVLDSPFPTGSAFGFSLRGAVDIDDNGYPDLIVGAYGANQVAVYRAQPVVKASVQLLVQDSLNPAVKSCVLPQTKT PVSCFNIQMCVGATGHNIPQKLSLNAELQLDRQKPRQGRRVLLLGSQQAGTTLNLDLGGKHSPICHTTMAFLRDEADFRD KLSPIVLSLNVSLPPTEAGMAPAVVLHGDTHVQEQTRIVLDCGEDDVCVPQLQLTASVTGSPLLVGADNVLELQMDAANE GEGAYEAELAVHLPQGAHYMRALSNVEGFERLICNQKKENETRVVLCELGNPMKKNAQIGIAMLVSVGNLEEAGESVSFQ LQIRSKNSQNPNSKIVLLDVPVRAEAQVELRGNSFPASLVVAAEEGEREQNSLDSWGPKVEHTYELHNNGPGTVNGLHLS IHLPGQSQPSDLLYILDIQPQGGLQCFPQPPVNPLKVDWGLPSPSPSPIHPAHHKRDRRQIFLPEPEQPSRLQDPVLVSC DSAPCTVVQCDLQEMARGQRAMVTVLAFLWLPSLYQRPLDQFVLQSHAWFNVSSLPYAVPPLSLPRGEAQVWTQLLRALE ERAIPIWWVLVGVLGGLLLLTILVLAMWKVGF ..............N................................................................. ................................................................................ ................................................................................ ........N....................................................................... ................................................................................ ................................................................................ ................................................................................ .........N...................................................................... .......................................N........................................ ................................................................................ ..........................................S...S................................. ..................................................N............................. ................................ 144 GLP_MACFU (sprot) ( 18, 0) GLYCOPHORIN MK. - MACACA FUSCATA FUSCATA SSTTVPATHTSSSSLGPEQYVSSQSNDKHTSDSHPTPTSAHEVTTEFSGRTHYPPEEDDRVQLVHEFSELVIALIIFGVM AGVIGTILFISYGSRRLIKKSESDVQPLPPPDAEVPLSSVEIEDPEETDELNSFTKPNQERNES .STT...T.TSSSS.......SS......T.....T.T.....TT..S..T............................. ................................................................ 299 NBHUIA ( pir) ( 1, 0) platelet glycoprotein Ib alpha chain HPICEVSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRCELTKLQVDGTLPVLG TLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL TELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQDNAENVYVWKQGVDVKAMT SNVASVQCDNSDKFPVYKYPGKGCPTLGDEGDTDLYDYYPEEDTEGDKVRATRTVVKFP ....................N........................................................... ..............................................................................N. ................................................................................ ...................................................T....... 349 WOHU ( pir) ( 3, 0) alpha-2-HS-glycoprotein precursor - human APHGPGLIYRQPNCDDPETEEAALVAIDYINQNLPWGYKHTLNQIDEVKVWPQQPSGELFEIEIDTLETTCHVLDPTPVA RCSVRQLKEHAVEGDCDFQLLKLDGKFSVVYAKCDSSPDSAEDVRKVCQDCPLLAPLNDTRVVHAAKAALAAFNAQNNGS NFQLEEISRAQLVPLPPSTYVEFTVSGTDCVAKEATEAAKCNLLAEKQYGFCKATLSEKLGGAEVAVTCTVFQTQPVTSQ PQPEGANEAVPTPVVDPDAPPSPPLGAPGLPPAGSPPDSHVLLAAPPGHQLHRAHYDLRHTFMGVVSLGSPSGEVSHPRK TRTVVQPSVGAAAGPVVPPCPGRIRHFKV ................................................................................ .........................................................N...................N.. .............................................................................T.. ...........T.................................................................... .......S..................... 500 ITHUC1 ( pir) ( 7, 8) complement C1 inhibitor precursor - human MASRLTLLTLLLLLLAGDRASSNPNATSSSSQDPESLQDRGEGKVATTVISKMLFVEPILEVSSLPTTNSTTNSATKITA NTTDEPTTQPTTEPTTQPTIQPTQPTTQLPTDSPTQPTTGSFCPGPVTLCSDLESHSTEAVLGDALVDFSLKLYHAFSAM KKVETNMAFSPFSIASLLTQVLLGAGENTKTNLESILSYPKDFTCVHQALKGFTTKGVTSVSQIFHSPDLAIRDTFVNAS RTLYSSSPRVLSNNSDANLELINTWVAKNTNNKISRLLDSLPSDTRLVLLNAIYLSAKWKTTFDPKKTRMEPFHFKNSVI KVPMMNSKKYPVAHFIDQTLKAKVGQLQLSHNLSLVILVPQNLKHRLEDMEQALSPSVFKAIMEKLEMSKFQPTLLTLPR IKVTTSQDMLSIMEKLEFFDFSYDLNLCGLTEDPDLQVSAMQHQTVLELTETGVEAAAASAISVARTLLVFEVQQPFLFV LWDQQHKFPVFMGRVYDPRA ........................N......................T...............S....N.T......... N.T....T...T...T................................................................ .............................................................................N.. ............N................................................................... ...............................N................................................ ................................................................................ .................... 144 LITH_HUMAN (sprot) ( 1, 0) LITHOSTATHINE PRECURSOR (PSP) PEAQTELPQARISCPEGTNAYRSYCYYFNEDRETWVDADLYCQNMNSGNLVSVLTQAEGAFVASLIKESGTDDFNVWIGL HDPKKNRRWHWSSGSLVSYKSWGIGAPSSVNPGYCVSLTSSTGFQKWKDVPCEDKFSFVCKFKN ....T........................................................................... ................................................................ 299 APE_HUMAN (sprot) ( 1, 0) APOLIPOPROTEIN E (APO-E). KVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEE QLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLA VYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVR AKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH ................................................................................ ................................................................................ .................................T.............................................. ........................................................... 672 JXHU.1 ( pir) ( 1, 0) (e) transferrin receptor protein - human CKGVEPKTECERLAGTESPVREEPGEDFPAARRLYWDDLKRKLSEKLDSTDFTSTIKLLNENSYVPREAGSQKDENLALY VENQFREFKLSKVWRDQHFVKIQVKDSAQNSVIIVDKNGRLVYLVENPGGYVAYSKAATVTGKLVHANFGTKKDFEDLYT PVNGSIVIVRAGKITFAEKVANAESLNAIGVLIYMDQTKFPIVNAELSFFGHAHLGTGDPYTPGFPSFNHTQFPPSRSSG LPNIPVQTISRAAAEKLFGNMEGDCPSDWKTDSTCRMVTSESKNVKLTVSNVLKEIKILNIFGVIKGFVEPDHYVVVGAQ RDAWGPGAAKSGVGTALLLKLAQMFSDMVLKDGFQPSRSIIFASWSAGDFGSVGATEWLEGYLSSLHLKAFTYINLDKAV LGTSNFKVSASPLLYTLIEKTMQNVKHPVTGQFLYQDSNWASKVEKLTLDNAAFPFLAYSGIPAVSFCFCEDTDYPYLGT TMDTYKELIERIPELNKVARAAAEVAGQFVIKLTHDVELNLDYERYNSQLLSFVRDLNQYRADIKEMGLSLQWLYSARGD FFRATSRLTTDFGNAEKTDRFVMKKLNDRVMRVEYHFLSPYVSPKESPFRHVFWGSGSHTLPALLENLKLRKQNNGAFNE TLFRNQLALATWTIQGAANALSGDVWDIDNEF ...............T................................................................ ................................................................................ ..n.................................................................n........... ................................................................................ ................................................................................ ................................................................................ ................................................................................ ..............................................................................n. ................................ 165 IVHUA2 ( pir) ( 1, 0) interferon alpha-2 precursor - human. CDLPQTHSLGSRRTLMLLAQMRKISLFSCLKDRHDFGFPQEEFGNQFQKAETIPVLHEMIQQIFNLFSTKDSSAAWDETL LDKFYTELYQQLNDLEACVIQGVGVTETPLMKEDSILAVRKYFQRITLYLKEKKYSPCAWEVVRAEIMRSFSLSTNLQES LRSKE ................................................................................ .........................T...................................................... ..... 171 TNFB_HUMAN (sprot) ( 1, 0) LYMPHOTOXIN-ALPHA (LT-ALPHA) (TNF-BETA). LPGVGLTPSAAQTARQHPKMHLAHSTLKPAAHLIGDPSKQNSLLWRANTDRAFLQDGFSLSNNSLLVPTSGIYFVYSQVV FSGKAYSPKATSSPLYLAHEVQLFSSQYPFHVPLLSSQKMVYPGLQEPWLHSMYHGAAFQLTQGDQLSTHTDGIPHLVLS PSTVFFGAFAL ......T......................................................N.................. ................................................................................ ........... 1217 MMMSND ( pir) ( 7, 0) nidogen precursor - mouse entactin LNRQELFPFGPGQGDLELEAGDDVVSPSLELIGELSFYDRTDITSVYVTTNGIIAMSEPPATEYHPGTFPPSFGSVAPFL ADLDTTDGLGNVYYREDLSPFIIQMAAEYVQRGFPEVSFQPTSVVVVTWESVAPYGGPSSSPAEEGKRNTFQAVLASSNS SSYAIFLYPEDGLQFFTTFSKKDESQVPAVVGFSKGLVGFLWKSNGAYNIFANDRESIENLAKSSNAGHQGVWVFEIGSP ATAKGVVSADVNLDLDDDGADYEDEDYDLVTSHLGLEDVATPSPSHSPRRGYPDPHNVPRILSPGYEATERPRGVPTERT RSFQLPAERFPQHHPQVIDVDEVEETGVVFSYNTGSQQTCANNRHQCSVHAECRDYATGFCCRCVANYTGNGRQCVAEGS PQRVNGKVKGRIFVGSSQVPVVFENTDLHSYVVMNHGRSYTAISTIPETVGYSLLPLAPIGGIIGWMFAVEQDGFKNGFS ITGGEFTRQAEVTFLGHPGKLVLKQQFSGIDEHGHLTISTELEGRVPQIPYGASVHIEPYTELYHYSSSVITSSSTREYT VMEPDQDGAAPSHTHIYQWRQTITFQECAHDDARPALPSTQQLSVDSVFVLYNKEERILRYALSNSIGPVRDGSPDALQN PCYIGTHGCDSNAACRPGPGTQFTCECSIGFRGDGQTCYDIDECSEQPSRCGNHAVCNNLPGTFRCECVEGYHFSDRGTC VAAEDQRPINYCETGLHNCDIPQRAQCIYMGGSSYTCSCLPGFSGDGRACRDVDECQHSRCHPDAFCYNTPGSFTCQCKP GYQGDGFRCMPGEVSKTRCQLEREHILGAAGGADAQRPTLQGMFVPQCDEYGHYVPTQCHHSTGYCWCVDRDGRELEGSR TPPGMRPPCLSTVAPPIHQGPVVPTAVIPLPPGTHLLFAQTGKIERLPLERNTMKKTERKAFLHIPAKVIIGLAFDCVDK VVYWTDISEPSIGRASLHGGEPTTIIRQDLGSPEGIALDHLGRTIFWTDSQLDRIEVAKMDGTQRRVLFDTGLVNPRGIV TDPVRGNLYWTDWNRDNPKIETSHMDGTNRRILAQDNLGLPNGLTFDAFSSQLCWVDAGTHRAECLNPAQPGRRKVLEGL QYPFAVTSYGKNLYYTDWKTNSVIAMDLAISKEMDTFHPHKQTRLYGITIALSQCPQGHNYCSVNNGGCTHLCLPTPGSR TCRCPDNTLGVDCIERK ................................................................................ ..............................................................................n. ................................................................................ ..............................T...............................S.....T.......T..T ..................................................................N............. ................................................................................ ................................................................................ ................................................................................ ................................................................................ ................................................................................ ................................................................................ ...........T............T....................................................... ................................................................................ ................................................................................ ................................................................................ ................. 174 A25093 ( pir) ( 1, 0) granulocyte colony-stimulating factor precursor TPLGPASSLPQSFLLKCLEQVRKIQGDGAALQEKLCATYKLCHPEELVLLGHSLGIPWAPLSSCPSQALQLAGCLSQLHS GLFLYQGLLQALEGISPELGPTLDTLQLDVADFATTIWQQMEELGMAPALQPTQGAMPAFASAFQRRAGGVLVASHLQSF LEVSYRVLRHLAQP ................................................................................ ....................................................T........................... .............. 445 ENV_MLVFR (sprot) ( 7, 0) KNOB PROTEIN GP70. - FRIEND MURINE LEUKEMIA AAPGSSPHQVYNITWEVTNGDRETVWAISGNHPLWTWWPVLTPDLCMLALHGPPHWGLEYQAPYSSPPGPPCCSGSGGSS PGCSRDCNEPLTSLTPRCNTAWNRLKLDQVTHKSSEGFYVCPGSHRPREAKSCGGPDSFYCASWGCETTGRAYWKPSSSW DYITVDNNLTTNQAVQVCKDNKWCNPLAIQFTNAGRQVTSWITGHYWGLRLYVSGQDPGLTFGIRLKYQNLGPRVPIGPN PVLADQLSFPLPNPLPKPAKSPPVSNSTPTMISPSPTPTQPPPAGTGDRLLNLVQGAYQALNLTNPDKTQECWLCLVSGP PYYEGVAVLGTYSNHTSAPTNCSVASQHKLTLSEVTGRGLCIGTVPKTHQALCNTTLKTNKGSYYLVAPAGTTWACNTGL TPCLSATVLNRTTDYCVLVELWPRVTYHPPSYVYSQFEKSYRHKR ...........N.................................................................... ................................................................................ ................................................................................ ...........................T....S.S.T.T........................T....T........... ................................................................................ ............................................. 115 IL5_HUMAN (sprot) ( 1, 0) INTERLEUKIN-5 (IL-5) IPTEIPTSALVKETLALLSTHRTLLIANETLRIPVPVHKNHQLCTEEIFQGIGTLESQTVQGGTVERLFKNLSLIKKYID GQKKKCGEERRRVNQFLDYLQEFLGVMNTEWIIES ..T........................N.................................................... ................................... 156 IGHU2 ( pir) ( 1, 0) insulin-like growth factor II precursor - human AYRPSETLCGGELVDTLQFVCGDRGFYFSRPASRVSRRSRGIVEECCFRSCDLALLETYCATPAKSERDVSTPPTVLPDN FPRYPVGKFFQYDTWKQSTQRLRRGLPALLRARRGHVLAKELEAFREAKRHRPLIALPTQDPAHGGAPPEMASNRK ..........................................................................T..... ............................................................................ 92 TTHUAP ( pir) ( 1, 0) thyrotropin/gonadotropin alpha chain precursor APDVQDCPECTLQENPFFSQPGAPILQCMGCCFSRAYPTPLRSKKTMLVQKNVTSESTCCVAKSYNRVTVMGGFKVENHT ACHCSTCYYHKS ......................................T............N.........................N.. ............